The characteristic of endogenous IGF-1 desensitization in IBD is the downregulation of IRS1/2, AKT and mTOR signaling cascade reaction [61] which is also the downstream signaling axis regulated by APN through AdipoR1/2 [17, 22, 47]. Here, MTOR is linked to inflammatory bowel disease.